XTANT MEDICAL HOLDINGS INC (XTNT) Forecast, Price Target & Analyst Ratings

NYSEARCA:XTNTUS98420P3082

Current stock price

0.58 USD
-0.02 (-3.81%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XTANT MEDICAL HOLDINGS INC (XTNT).

Forecast Snapshot

Consensus Price Target

Price Target
$1.53
+ 163.79% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 20, 2026
Period
Q4 / 2025
EPS Estimate
-$0.01
Revenue Estimate
31.365M

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.53
Upside
+ 163.79%
From current price of $0.58 to mean target of $1.53, Based on 8 analyst forecasts
Low
$1.52
Median
$1.53
High
$1.58

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for XTNT. The average price target is 1.53 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 0.58.

Analyst Ratings & History

Current Analyst Ratings

XTNT Current Analyst RatingXTNT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XTNT Historical Analyst RatingsXTNT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
XTNT was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about XTNT.
In the previous month the buy percentage consensus was at a similar level.
XTNT was analyzed by 8 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-11BTIGMaintains Buy -> Buy
2024-05-16BTIGMaintains Buy -> Buy
2023-12-05BTIGInitiate Buy
2023-07-11Craig-HallumMaintains Buy -> Buy
2023-04-26Craig-HallumInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 20, 2026
Period
Q4 / 2025
EPS Estimate
-$0.01
Revenue Estimate
31.365M
Revenue Q2Q
-0.47%
EPS Q2Q
74.50%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

XTNT is expected to report earnings on 3/20/2026. The consensus EPS estimate for the next earnings is -0.01 USD and the consensus revenue estimate is 31.36M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
XTNT revenue by date.XTNT revenue by date.
57.969M
4.90%
91.303M
57.50%
117.267M
28.44%
134.95M
15.08%
115.46M
-14.44%
126.02M
9.15%
EBITDA
YoY % growth
XTNT ebitda by date.XTNT ebitda by date.
-5.463M
-116.61%
-6.984M
-27.84%
-7.85M
-12.40%
14.586M
285.81%
9.129M
-37.41%
10.608M
16.20%
EBIT
YoY % growth
XTNT ebit by date.XTNT ebit by date.
-6.755M
-75.27%
-10.158M
-50.38%
-12.074M
-18.86%
8.109M
167.16%
3.417M
-57.86%
6.681M
95.52%
Operating Margin
XTNT operating margin by date.XTNT operating margin by date.
-11.65%-11.13%-10.30%6.01%2.96%5.30%
EPS
YoY % growth
XTNT eps by date.XTNT eps by date.
N/A0.00-0.12
-1,729,382,256,910,270,500.00%
0.03
121.25%
0.01
-80.00%
0.03
400.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.01
74.50%
0.000.00
-100.00%
0.00
-100.00%
0.01
200.00%
0.000.010.010.00
-100.00%
Revenue
Q2Q % growth
31.365M
-0.47%
29.07M
-11.65%
30.192M
-14.74%
27.234M
-18.11%
28.968M
-7.64%
31.671M
8.95%
32.997M
9.29%
29.58M
8.61%
31.875M
10.04%
EBITDA
Q2Q % growth
1.224M
-47.74%
2.04M
-4.54%
2.193M
-68.06%
2.397M
-30.88%
2.55M
108.33%
3.366M
65.00%
3.774M
72.09%
3.774M
57.45%
4.284M
68.00%
EBIT
Q2Q % growth
-255K
86.45%
612K
-42.43%
714K
-84.56%
969K
280.00%
1.122M
540.00%
1.428M
133.33%
1.734M
142.86%
1.836M
89.47%
2.244M
100.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XTNT Yearly Revenue VS EstimatesXTNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
XTNT Yearly EPS VS EstimatesXTNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.31%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.69%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
42.24%
EBIT Next 5 Year
N/A

XTANT MEDICAL HOLDINGS INC / XTNT Forecast FAQ

Can you provide the average price target for XTANT MEDICAL HOLDINGS INC stock?

8 analysts have analysed XTNT and the average price target is 1.53 USD. This implies a price increase of 163.79% is expected in the next year compared to the current price of 0.58.

What is the next earnings date for XTNT stock?

XTANT MEDICAL HOLDINGS INC (XTNT) will report earnings on 2026-03-20, before the market open.

What are the consensus estimates for XTANT MEDICAL HOLDINGS INC (XTNT) next earnings?

The consensus EPS estimate for the next earnings of XTANT MEDICAL HOLDINGS INC (XTNT) is -0.01 USD and the consensus revenue estimate is 31.36M USD.

Can you provide the analyst count for XTANT MEDICAL HOLDINGS INC stock?

The number of analysts covering XTANT MEDICAL HOLDINGS INC (XTNT) is 8.